Literature DB >> 32801145

Predicting functional effects of missense variants in voltage-gated sodium and calcium channels.

Henrike O Heyne1,2,3,4, David Baez-Nieto3, Sumaiya Iqbal5,2,3,6, Duncan S Palmer5,2,3, Andreas Brunklaus7,8, Patrick May9, Katrine M Johannesen10,11, Stephan Lauxmann12, Johannes R Lemke13, Rikke S Møller10,11, Eduardo Pérez-Palma14,15, Ute I Scholl16,17, Steffen Syrbe18, Holger Lerche12, Dennis Lal5,2,3,14,15,19, Arthur J Campbell3,6, Hao-Ran Wang3, Jen Pan3, Mark J Daly1,2,3,4.   

Abstract

Malfunctions of voltage-gated sodium and calcium channels (encoded by SCNxA and CACNA1x family genes, respectively) have been associated with severe neurologic, psychiatric, cardiac, and other diseases. Altered channel activity is frequently grouped into gain or loss of ion channel function (GOF or LOF, respectively) that often corresponds not only to clinical disease manifestations but also to differences in drug response. Experimental studies of channel function are therefore important, but laborious and usually focus only on a few variants at a time. On the basis of known gene-disease mechanisms of 19 different diseases, we inferred LOF (n = 518) and GOF (n = 309) likely pathogenic variants from the disease phenotypes of variant carriers. By training a machine learning model on sequence- and structure-based features, we predicted LOF or GOF effects [area under the receiver operating characteristics curve (ROC) = 0.85] of likely pathogenic missense variants. Our LOF versus GOF prediction corresponded to molecular LOF versus GOF effects for 87 functionally tested variants in SCN1/2/8A and CACNA1I (ROC = 0.73) and was validated in exome-wide data from 21,703 cases and 128,957 controls. We showed respective regional clustering of inferred LOF and GOF nucleotide variants across the alignment of the entire gene family, suggesting shared pathomechanisms in the SCNxA/CACNA1x family genes.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32801145     DOI: 10.1126/scitranslmed.aay6848

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  18 in total

1.  Autism-associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses.

Authors:  Michael Bucher; Stephan Niebling; Yuhao Han; Dmitry Molodenskiy; Fatemeh Hassani Nia; Hans-Jürgen Kreienkamp; Dmitri Svergun; Eunjoon Kim; Alla S Kostyukova; Michael R Kreutz; Marina Mikhaylova
Journal:  Elife       Date:  2021-05-04       Impact factor: 8.140

2.  Genetic Landscape of SCN1A Variants in a Turkish Cohort with GEFS+ Spectrum and Dravet Syndrome.

Authors:  Ayberk Türkyılmaz; Emine Tekin; Oğuzhan Yaralı; Alper Han Çebi
Journal:  Mol Syndromol       Date:  2022-02-22

Review 3.  Genetic pain loss disorders.

Authors:  Annette Lischka; Petra Lassuthova; Arman Çakar; Christopher J Record; Jonas Van Lent; Jonathan Baets; Maike F Dohrn; Jan Senderek; Angelika Lampert; David L Bennett; John N Wood; Vincent Timmerman; Thorsten Hornemann; Michaela Auer-Grumbach; Yesim Parman; Christian A Hübner; Miriam Elbracht; Katja Eggermann; C Geoffrey Woods; James J Cox; Mary M Reilly; Ingo Kurth
Journal:  Nat Rev Dis Primers       Date:  2022-06-16       Impact factor: 65.038

4.  Clinical and genetic characterization of CACNA1A-related disease.

Authors:  Amy R Lipman; Xiao Fan; Yufeng Shen; Wendy K Chung
Journal:  Clin Genet       Date:  2022-06-26       Impact factor: 4.296

5.  Identification of discriminative gene-level and protein-level features associated with pathogenic gain-of-function and loss-of-function variants.

Authors:  Cigdem Sevim Bayrak; David Stein; Aayushee Jain; Kumardeep Chaudhary; Girish N Nadkarni; Tielman T Van Vleck; Anne Puel; Stephanie Boisson-Dupuis; Satoshi Okada; Peter D Stenson; David N Cooper; Avner Schlessinger; Yuval Itan
Journal:  Am J Hum Genet       Date:  2021-11-10       Impact factor: 11.043

6.  Novel Fluorescence-Based High-Throughput FLIPR Assay Utilizing Membrane-Tethered Genetic Calcium Sensors to Identify T-Type Calcium Channel Modulators.

Authors:  Yan-Ling Zhang; Sean P Moran; Andrew Allen; David Baez-Nieto; Qihong Xu; Lei A Wang; William E Martenis; Joshua R Sacher; Jennifer P Gale; Michel Weïwer; Florence F Wagner; Jen Q Pan
Journal:  ACS Pharmacol Transl Sci       Date:  2022-02-25

7.  MYT1L: A systematic review of genetic variation encompassing schizophrenia and autism.

Authors:  Patricia Mansfield; John N Constantino; Dustin Baldridge
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-04-08       Impact factor: 3.568

8.  Assessing the impact of pain-linked Nav1.7 variants: An example of two variants with no biophysical effect.

Authors:  Kim Le Cann; Jannis E Meents; Vishal Sudha Bhagavath Eswaran; Maike F Dohrn; Raya Bott; Andrea Maier; Martin Bialer; Petra Hautvast; Andelain Erickson; Roman Rolke; Markus Rothermel; Jannis Körner; Ingo Kurth; Angelika Lampert
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

9.  MVP predicts the pathogenicity of missense variants by deep learning.

Authors:  Hongjian Qi; Haicang Zhang; Yige Zhao; Chen Chen; John J Long; Wendy K Chung; Yongtao Guan; Yufeng Shen
Journal:  Nat Commun       Date:  2021-01-21       Impact factor: 14.919

10.  Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants.

Authors:  Sumaiya Iqbal; Eduardo Pérez-Palma; Jakob B Jespersen; Patrick May; David Hoksza; Henrike O Heyne; Shehab S Ahmed; Zaara T Rifat; M Sohel Rahman; Kasper Lage; Aarno Palotie; Jeffrey R Cottrell; Florence F Wagner; Mark J Daly; Arthur J Campbell; Dennis Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.